Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 244

1.

Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil.

Moretti ML, Trabasso P, Lyra L, Fagnani R, Resende MR, de Oliveira Cardoso LG, Schreiber AZ.

Med Mycol. 2013 Apr;51(3):225-30. doi: 10.3109/13693786.2012.708107. Epub 2012 Aug 27.

PMID:
22920712
2.

Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals.

Colombo AL, Garnica M, Aranha Camargo LF, Da Cunha CA, Bandeira AC, Borghi D, Campos T, Senna AL, Valias Didier ME, Dias VC, Nucci M.

Med Mycol. 2013 Jan;51(1):38-44. doi: 10.3109/13693786.2012.698024. Epub 2012 Jul 5.

PMID:
22762208
3.

Prevalence, susceptibility profile for fluconazole and risk factors for candidemia in a tertiary care hospital in southern Brazil.

Aquino VR, Lunardi LW, Goldani LZ, Barth AL.

Braz J Infect Dis. 2005 Oct;9(5):411-8. Epub 2006 Jan 6.

4.

Six-year trend analysis of nosocomial candidemia and risk factors in two intensive care hospitals in Mato Grosso, midwest region of Brazil.

Hoffmann-Santos HD, Paula CR, Yamamoto AC, Tadano T, Hahn RC.

Mycopathologia. 2013 Dec;176(5-6):409-15. doi: 10.1007/s11046-013-9705-5. Epub 2013 Oct 11.

PMID:
24113801
5.

Nosocomial bloodstream Candida infections in a tertiary-care hospital in South Brazil: a 4-year survey.

da Costa VG, Quesada RM, Abe AT, Furlaneto-Maia L, Furlaneto MC.

Mycopathologia. 2014 Oct;178(3-4):243-50. doi: 10.1007/s11046-014-9791-z. Epub 2014 Aug 8.

PMID:
25103140
6.

Seven-year trend analysis of nosocomial candidemia and antifungal (fluconazole and caspofungin) use in Intensive Care Units at a Brazilian University Hospital.

Girão E, Levin AS, Basso M, Gobara S, Gomes LB, Medeiros EA, Costa SF.

Med Mycol. 2008 Sep;46(6):581-8. doi: 10.1080/13693780802004996.

PMID:
19180727
7.

Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study.

Tadec L, Talarmin JP, Gastinne T, Bretonnière C, Miegeville M, Le Pape P, Morio F.

Mycoses. 2016 May;59(5):296-303. doi: 10.1111/myc.12470. Epub 2016 Jan 25.

PMID:
26806101
8.

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.

Arendrup MC, Dzajic E, Jensen RH, Johansen HK, Kjaeldgaard P, Knudsen JD, Kristensen L, Leitz C, Lemming LE, Nielsen L, Olesen B, Rosenvinge FS, Røder BL, Schønheyder HC.

Clin Microbiol Infect. 2013 Aug;19(8):E343-53. doi: 10.1111/1469-0691.12212. Epub 2013 Apr 22. Erratum in: Clin Microbiol Infect. 2013 Aug;19(8):E376.

9.

[Candidemia in a Brazilian tertiary care hospital: incidence, frequency of different species, risk factors and antifungal susceptibility].

França JC, Ribeiro CE, Queiroz-Telles Fd.

Rev Soc Bras Med Trop. 2008 Jan-Feb;41(1):23-8. Portuguese.

10.

Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.

Blanco-Blanco MT, Gómez-García AC, Hurtado C, Galán-Ladero MA, Lozano Mdel C, García-Tapias A, Blanco MT.

Rev Iberoam Micol. 2014 Apr-Jun;31(2):145-8. doi: 10.1016/j.riam.2013.04.001. Epub 2013 May 13.

PMID:
23680638
11.

Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain.

Bassetti M, Merelli M, Righi E, Diaz-Martin A, Rosello EM, Luzzati R, Parra A, Trecarichi EM, Sanguinetti M, Posteraro B, Garnacho-Montero J, Sartor A, Rello J, Tumbarello M.

J Clin Microbiol. 2013 Dec;51(12):4167-72. doi: 10.1128/JCM.01998-13. Epub 2013 Oct 9.

12.

Epidemiology and cost implications of candidemia, a 6-year analysis from a developing country.

Ulu Kilic A, Alp E, Cevahir F, Ture Z, Yozgat N.

Mycoses. 2017 Mar;60(3):198-203. doi: 10.1111/myc.12582. Epub 2016 Nov 9.

PMID:
27862414
13.

Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program.

Doi AM, Pignatari AC, Edmond MB, Marra AR, Camargo LF, Siqueira RA, da Mota VP, Colombo AL.

PLoS One. 2016 Jan 25;11(1):e0146909. doi: 10.1371/journal.pone.0146909. eCollection 2016.

14.

Characteristics and risk factors of candidemia in pediatric intensive care unit of a tertiary care children's hospital in Egypt.

Hegazi M, Abdelkader A, Zaki M, El-Deek B.

J Infect Dev Ctries. 2014 May 14;8(5):624-34. doi: 10.3855/jidc.4186.

15.

Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.

Lin CC, Liu CP, Hsieh FC, Lee CM, Wang WS.

J Microbiol Immunol Infect. 2015 Oct;48(5):552-8. doi: 10.1016/j.jmii.2014.07.007. Epub 2014 Oct 12.

16.

Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality.

Colombo AL, Guimarães T, Silva LR, de Almeida Monfardini LP, Cunha AK, Rady P, Alves T, Rosas RC.

Infect Control Hosp Epidemiol. 2007 May;28(5):570-6. Epub 2007 Apr 13.

PMID:
17464917
17.

Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.

Martí-Carrizosa M, Sánchez-Reus F, March F, Coll P.

Scand J Infect Dis. 2014 Jun;46(6):454-61. doi: 10.3109/00365548.2014.900190. Epub 2014 Apr 24.

PMID:
24762093
18.

Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.

Lin MY, Carmeli Y, Zumsteg J, Flores EL, Tolentino J, Sreeramoju P, Weber SG.

Antimicrob Agents Chemother. 2005 Nov;49(11):4555-60.

19.

Changing epidemiology of candidemia in a medical center in middle Taiwan.

Hii IM, Chang HL, Lin LC, Lee YL, Liu YM, Liu CE, Chen CH, Cheng YR, Chang CY.

J Microbiol Immunol Infect. 2015 Jun;48(3):306-15. doi: 10.1016/j.jmii.2013.08.017. Epub 2013 Oct 8.

20.

Evaluation of species distribution and risk factors of candidemia: a multicenter case-control study.

Yapar N, Pullukcu H, Avkan-Oguz V, Sayin-Kutlu S, Ertugrul B, Sacar S, Cetin B, Kaya O.

Med Mycol. 2011 Jan;49(1):26-31. doi: 10.3109/13693786.2010.501344. Epub 2010 Jul 22.

PMID:
20662635

Supplemental Content

Support Center